Jason A. Amello
Former Chief Financial OfficeratCandel Therapeutics· In the 2023 proxy
Pay in FY2023Candel Therapeutics stock -17.9% the same year
Jason A. Amello was paid $692.0K in FY2023 (Dec). Candel Therapeutics stock fell 17.9% that year.
Pay$100 in the stock at the end of FY22 → $82
Experience
- Candel TherapeuticsPublic company · 3 yr
- Former Chief Financial Officer2023 – Present · 3 yrStock in role +486%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?